Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2018, Article ID 6085730, 4 pages
Case Report

Large Bowel Obstruction Subsequent to Resected Lobular Breast Carcinoma: An Unconventional Etiology of Malignant Obstruction

1Department of Surgery, SBH Health System, Bronx, NY, USA
2New York Institute of Technology College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY, USA
3School of Medicine, City University of New York, New York, NY, USA

Correspondence should be addressed to Melissa Amberger; moc.liamg@regrebma.assilem

Received 8 April 2018; Accepted 28 May 2018; Published 13 June 2018

Academic Editor: Menelaos Zafrakas

Copyright © 2018 Melissa Amberger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Introduction. Breast cancer metastasis to the gastrointestinal tract is rare and mostly limited to case reports which recommend consideration of metastasis when breast cancer patients particularly those with invasive lobular carcinoma present with new gastrointestinal complaints. Presentation of case. We report a 50-year-old female who presented with gastrointestinal symptoms of nausea and vomiting determined to be the result of large bowel obstruction secondary to rectosigmoid metastasis and carcinomatosis of breast invasive lobular carcinoma. She was treated with diverting loop sigmoid colostomy for her large bowel obstruction. Discussion. Our case reflects the importance of gastrointestinal surveillance of patients with a history of breast cancer. Current National Comprehensive Cancer Network (NCCN) guidelines for stage I-II breast cancer suggest posttreatment lab and imaging evaluation for metastasis only if new symptoms present. Conclusion. We observed an unusually rapid disease progression, requiring evaluation of new gastrointestinal symptoms. Assessment for GI tract metastatic involvement should be done as early as progression to symptomatic disease can result in need for further invasive surgery in advanced stages of cancer.